MIT and Scripps scientists explore a single-dose vaccine approach by combining two immune-boosting ingredients.

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

A panelist discusses recent advancements in bispecific antibody therapies for relapsed/refractory multiple myeloma, ...

Our immune systems don't always react in the right way, but scientists are learning more about why that happens... | Genetics And Genomics ...

Hidden food sensitivities cause delayed immune reactions that escape allergy tests but trigger chronic inflammation and ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

Roche and Genentech have announced outcomes from the randomised, multi-centre, international Phase III SUNMO trial for those ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

Vermont Business Magazine Governor Phil Scott signed into law late yesterday further restrictions on the use of toxic perfluoroalkyl and polyfluoroalkyl substances (PFAS) in firefighting gear, dental ...